On March 3, 2026, the Centers for Medicare & Medicaid Services (CMS) issued Frequently Asked Questions (FAQs) about the Medicare GLP-1 Bridge (the Bridge).
The Bridge will offer early access to GLP-1 drugs for weight loss to eligible Medicare Part D beneficiaries.
In February 2026, Senators Elizabeth Warren (D-MA) and Josh Hawley (R-MO) introduced the Break Up Big Medicine Act (S. 3822). The bipartisan legislation, referred to the Senate Judiciary Committee, aims to prohibit pharmacy benefit managers (PBMs), health insurers, and prescription drug or medical device wholesalers from being under common ownership with certain medical service providers or provider groups, including in-patient or outpatient pharmacies.
The Academy of Managed Care Pharmacy (AMCP) supports reforming the 340B Drug Pricing Program. While the program is intended to serve as an essential safety net that allows eligible healthcare entities to stretch federal resources and improve pharmaceutical access for vulnerable populations, stronger oversight, transparency, and accountability mechanisms are necessary to ensure it operates as Congress intended and delivers maximum benefit to patients and communities.
The AMCP Research Institute announced the launch of a new medication therapy management (MTM) health care improvement initiative designed to assess and manage modifiable risk factors for dementia in asymptomatic, middle-aged adults. The initiative is supported by a generous grant from Lilly and aims to address critical gaps in the identification and intervention of early dementia risk.
Researchers from University of Utah Report Findings in Managed Care and Specialty Pharmacy (Optimization of Oncology Biomarker Testing In Managed Care: Best Practices and Consensus Recommendations From an Amcp Market Insights Program): Drugs and Therapies – Managed Care and Specialty Pharmacy
Reports Outline Follicular Lymphoma Study Results from Denise Wolff et al (AMCP Market Insights: Managed care approaches to bispecific antibodies with a focus on follicular lymphoma and diffuse large B-cell lymphoma): Oncology – Follicular Lymphoma
Findings from Ryan Haumschild et al Update Understanding of Mucopolysaccharidoses (AMCP Market Insights: The role of managed care in improving patient care in mucopolysaccharidoses): Nutritional and Metabolic Diseases and Conditions – Mucopolysaccharidoses
